Patient and prescriber survey: effectiveness measures to investigate awareness, knowledge, and adherence to the additional risk minimisation measures (aRMM) of the patient reminder card for oral ambrisentan (PrVolibris®)
2025-04-16
عنوان الدراسة
Patient and prescriber survey: effectiveness measures to investigate awareness, knowledge, and adherence to the additional risk minimisation measures (aRMM) of the patient reminder card for oral ambrisentan (PrVolibris®)
داعم الدراسة
GSK
دواء الدراسة
Ambrisentan
رقم بروتوكول الدراسة
221772
حالة الدراسة
Ongoing
موقع الدراسة
King Abdullah International Medical Research Center– Jeddah
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。